TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Yale-Brown Obsessive Compulsive Scale (Y-BOCS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pulse wave velocity (aortic and brachial)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Improve Angina Symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Improve Quality of Life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in Visual-Motor Integration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Residual Neuromuscular Blockade
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Marginal reflex distance-1 (MRD-1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Palpebral fissure height
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Free time of pulmonary exacerbation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: incidence of vocal cord injuries
Endpoint domain: Adverse events/effects
Primary endpoint: Area Under the Receiver Operating Characteristic (ROC) Curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Calibration Slope
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of SpO2 measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Accuracy of Respiratory Rate measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Plasma glucose profile (AUC and Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Amplitude values of stimulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Latency values of stimulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change from baseline in self-reported health
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean change from baseline in cortisol, nmol/L
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Mean change from baseline in blood sugar (HBA1C), mmol/mol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: ANI value variation (%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cerebrospinal Fluid (CSF) Soluble Alpha-cleaved Amyloid Precursor Protein (APPsα) Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Conversion rate from Brand Name to Generic Prescription Medication
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: learning/working memory
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: motoric functions - Berg Balance Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of subjects rating the autoinjector as 'Easy to Use' or 'Very Easy to Use'
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in biochemical markers (GH, IGF-1, CgA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Intratumoral Gemcitabine Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Gemcitabine DNA Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Employed status by study year
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Total earnings from employment and/or self-employment by study year
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Dosimetry Changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of classifying colorectal polyps
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximal exercise capacity during hypoxia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in patient adherence to stroke rehabilitation plan
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Relative bioavailability of BMN 673
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Grade 3 or 4 or greater adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Assessment of cardiac conduction intervals via 12-lead electrocardiogram (ECG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Assessment of vital signs (including blood pressure and pulse rate)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urinary bisphenol A levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Salivary bisphenol A levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: %DNA methylation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: %DNA hydroxymethylation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Root mean square (RMS) of the electromyogram signal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Type of induced ventricular arrhythmias
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Spontaneous ventricular arrhythmias
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Type of spontaneous ventricular arrhythmias
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: RNA gene expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Forced Expiratory Volume In 1 Second (FEV1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Percent Change in the 17-item Hamilton Depression (HAM-D17) Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Amount of Serum Alanine Transaminase (ALT) at Baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent Change From Baseline in Serum ALT at Month 4
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall survivals
Endpoint domain: Mortality/survival
Primary endpoint: Change in Muscular Strength and Endurance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Pain score values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of Life Scale (PedsQL 3.0 Cancer Module) Scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Psychosocial status (depression, anxiety)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Knee Injury and Osteoarthritis Outcome Score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: 3-year Overall Survival Rate
Endpoint domain: Mortality/survival
Primary endpoint: 3-year Event-free Survival Rate
Endpoint domain: Mortality/survival
Primary endpoint: Dose Normalized Area Under the Curve (AUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients with clinically significant findings in vital signs (blood pressure, heart rate)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Assessment of global tolerability by investigator on a 4-point scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: bowel preparation scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: the amount of air bubbles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Regional expansion of valve prosthesis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Overall expansion of valve prosthesis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean number of medications prescribed
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Area under the plasma concentration versus time profile (AUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Awareness level about cervical cancer
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Intermediate Care indication
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intermediate Care benefit
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Short term survival
Endpoint domain: Mortality/survival
Primary endpoint: Patient deaths while awaiting a transplant
Endpoint domain: Mortality/survival
Primary endpoint: Disease progression while awaiting a transplant
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Total Score on the BDD-Y-BOCS Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IIEF-5 Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: End Diastolic Velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Development of Post-Concussive Syndrome (PCS) and/or Posttraumatic Stress Disorder (PTSD)
Endpoint domain: Adverse events/effects
Primary endpoint: Response rate in patients with advanced hepatobiliary carcinoma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Safety and efficacy of intratumoral CpG injections
Endpoint domain: Adverse events/effects
Primary endpoint: Responder Rate at Week 4
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Worst Pain 24 Hours Post Surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Medication Taking Adherence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: System Positive Detection Accuracy (PDA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the cumulative incidence rate of diarrhea at 4 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Change in the cumulative incidence rate of acute respiratory infections at 4 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: AG concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: UAG concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Obestatin concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Optic Disc Size
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Retinal Nerve Fiber Layer (RNFL) Thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Full Retinal Thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Optic Disc Cup Size
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Death post-TAVI
Endpoint domain: Mortality/survival
Primary endpoint: Change from baseline in visual assessment scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Circadian variation of melatonin and cortisol secretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Tolerability and safety of the treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Hospital admission within 7 days
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Change from Baseline Heart Rate Variability (HRV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Childhood epilepsy prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Number of subjects with dose-limiting toxicities (DLTs)
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency and type of adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Diagnostic accuracy of tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean (SD) number of prescription drugs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Mean (SD) number of over-the-counter drugs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Mean (SD) modified Morisky adherence score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: 13C phenylalanine enrichment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: 13CO2 enrichment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Renal Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Median nerve injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Brain perfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Contact Lens Corrected Distance Visual Acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of lice-free subjects
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: STAI anxiety score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of patients with changes from baseline in progression of atherosclerosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of serious adverse events or withdrawals due to adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Household Food Insecurity Access Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Hopkins Symptom Checklist Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Reduction in Number of Incontinence Episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inclinometer and actigraph assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of Pre-treatment Images Correctly Identified
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of safety events
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Any On-treatment Adverse Event (AE) or Any Serious Adverse Event (SAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Nasal inflammatory microbiome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: cytokine concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Changes in oxidative status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Implant Loss
Endpoint domain: Adverse events/effects
Primary endpoint: Percent Change in Lumbar Spine Bone Mineral Density (BMD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants That Experienced an Adverse Event (AE)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants That Discontinued Study Drug Due to an AE
Endpoint domain: Adverse events/effects
Primary endpoint: Diagnostic accuracy for HCC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of myofibrillar muscle protein synthesis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of Sarcoplasmic muscle protein synthesis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in percent total sleep time spent snoring
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Sustained Virological Response (SVR) at Week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Generation of metabolome profiles that reflect nutritional status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Utility of metabolome profiles in predicting relative risk of developing breast cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Identification of critical serum metabolites
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Opioid and cocaine use
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Proportion of patients with documented Sars-CoV2 infection
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of patients who tolerated treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Participant initiation of treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Serum Aflatoxin Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Eradication of H. Pylori
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: proportion of patients who die in accordance with their stated preferences
Endpoint domain: Mortality/survival
Primary endpoint: Percent change in erythema
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent change in PGE2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent change in COX-1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent change in COX-2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent change in proliferative index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent change in apoptotic index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gilliam autism rating scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Changes in pain pressure threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Depression measured by MADRS
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Maximum Tolerated Dose of HSP990
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 7 day point prevalence of cigarette abstinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: resting energy expenditure: leptin ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Prevalence of sleep apnea
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Recurrence rate of shoulder dislocation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Efficacy of the procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Toxicities of D-1MT
Endpoint domain: Adverse events/effects
Primary endpoint: Efficacy of D-1MT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence or absence of parenchymal abnormalities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: photoirritant index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: change from baseline in minimum erythemal dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Number of patients with full colonic exploration and detection of lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Blood Stem cell harvest failure rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: subjective disease symptoms
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: oral dryness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: myoartralgia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Cardiovascular ability (anaerobic threshold and peak VO2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: PCR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants Achieving a Validated Investigator's Global Assessment for Atopic Dermatitis (vIGA-AD) Score of 0 or 1 with a ≥ 2-point Improvement from Baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rabies virus neutralizing antibody concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: American shoulder and elbow surgeons score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Number of participants achieving dose-limiting toxicity (DLT)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants with adverse events (AEs) and serious adverse events (SAEs) by severity
Endpoint domain: Adverse events/effects
Primary endpoint: Change in fat metabolism from fed to fasted state
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in carbohydrates metabolism from fed to fasted state
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in myocardial blood flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Time to Virological failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes